Monthly Archive: March, 2016

Will Riluzole really be good for cerebellar ataxia?

This is just a quick post on a recent paper in Lancet Neurology which looked at the potential benefit of Riluzole in the treatment of cerebellar ataxia. Neurologist know Riluzole very well. It is… Continue reading

13 unexpected and unusual reports about Parkinson’s disease

Parkinson’s disease (PD) looms large in neurology. As I try to make sense of developments in this field, I am struck by the large number of curious reports emerging all around it. I thought I had covered… Continue reading

Minocycline-induced vasculitic neuropathy

This is a quick post to highlight the association of minocycline and neuropathy.   This comes from an article in Neurology titled Vasculitic neuropathy following exposure to minocycline. Minocycline is an antibiotic commonly used in the… Continue reading

Migraine and its strange and surprising associations

I am casting my sight on the scourge of millions around the world-migraine. This post is a prelude to a piece I am working on titled How is migraine research soothing the pain of neurology? In doing this,… Continue reading

The emerging progress from the world of MS

Multiple sclerosis (MS) takes a large chunk of neurological practice. This is not only because it is common, but also because of its devastating impact. It predominantly affects the young, and deals a… Continue reading

Is neurology research finally breaking the resolve of MND?

Motor neurone disease (MND) is, to say the least, dreadful. It also doesn’t help that the terminology neurologists use adds to the distress. West of the Atlantic, amyotrophic lateral sclerosis (ALS) means MND but goes… Continue reading

Why is neuromyelitis optica (NMO) endlessly surprising neurology?

Neuromyelitis optica (NMO) may be seen as the rarer and more mysterious cousin of multiple sclerosis (MS). It is characterised by a long segment of inflammation in the spinal cord, and this occurs almost simultaneously with inflammation of… Continue reading